U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula 2C5H7O2.Cu
Molecular Weight 261.762
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of COPPER(II) 4-OXOPENT-2-EN-2-OLATE

SMILES

[Cu++].CC(=O)[CH-]C(C)=O.CC(=O)[CH-]C(C)=O

InChI

InChIKey=KMOVDRADWUSGIH-UHFFFAOYSA-N
InChI=1S/2C5H7O2.Cu/c2*1-4(6)3-5(2)7;/h2*3H,1-2H3;/q2*-1;+2

HIDE SMILES / InChI

Molecular Formula C5H8O2
Molecular Weight 100.1158
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula Cu
Molecular Weight 63.546
Charge 2
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description
Curator's Comment: description was created based on several sources, including: http://repositorio.unicamp.br/bitstream/REPOSIP/93476/1/2-s2.0-27844469706.pdf | DOI: 10.1002/047084289X.rc204.pub2

COPPER(II) 4-OXOPENT-2-EN-2-OLATE (Copper(II) acetylacetonate [Cu(acac)2]) is a soluble copper catalyst that has been widely employed in many types of reactions. It is a powerful reagent in organic synthesis. Anticancer properties of Copper(II) acetylacetonate complex was found by treating different cancer cell lines. The TUNEL assay showed a strong positivity in the C6 cells treated with Cu(acac)2 and this indicates that the Cu compounds initiated cell death by DNA fragmentation.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Target ID: CHEMBL2311221
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Patents

Sample Use Guides

In Vivo Use Guide
Unknown
Route of Administration: Unknown
Low doses of Copper(II) acetylacetonate alone were necessary to kill approximately 90% of cells of different cancer cell lines (C6, RG2, B16, and U373) (∼62.5 mg/mL).
Substance Class Chemical
Created
by admin
on Sat Dec 16 08:58:01 GMT 2023
Edited
by admin
on Sat Dec 16 08:58:01 GMT 2023
Record UNII
69QQY9TJ8M
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
COPPER(II) 4-OXOPENT-2-EN-2-OLATE
Systematic Name English
COPPER BIS(ACETYLACETONE)
Systematic Name English
BIS(ACETYLACETONE)COPPER
Common Name English
COPPER, BIS(2,4-PENTANEDIONATO-.KAPPA.O2,.KAPPA.O4)-, (SP-4-1)-
Systematic Name English
COPPER BIS(2,4-PENTANEDIONATE)
Common Name English
COPPER DIACETYLACETONATE
Common Name English
COPPER, BIS(2,4-PENTANEDIONATO-O,O')-, (SP-4-1)-
Systematic Name English
BIS(ACETYLACETONATO)COPPER
Common Name English
CUPRIC ACETYLACETONATE [HSDB]
Common Name English
COPPER(II) BIS(2,4-PENTANEDIONATE)
Common Name English
COPPER, BIS(2,4-PENTANEDIONATO-.KAPPA.O,.KAPPA.O')-, (SP-4-1)-
Systematic Name English
COPPER(II) ACETYLACETONATE
Common Name English
COPPER BIS(ACETYLACETONATE)
Common Name English
BIS(2,4-PENTANEDIONATO)COPPER
Common Name English
COPPER(2+) BIS(ACETYLACETONATE)
Common Name English
CUPRIC ACETYLACETONATE
HSDB  
Common Name English
NACEM COPPER
Brand Name English
COPPER, BIS(2,4-PENTANEDIONATO)-
Systematic Name English
CUPRIC BIS(2,4-PENTANEDIONATE)
Common Name English
Code System Code Type Description
CAS
13395-16-9
Created by admin on Sat Dec 16 08:58:01 GMT 2023 , Edited by admin on Sat Dec 16 08:58:01 GMT 2023
PRIMARY
EPA CompTox
DTXSID50904281
Created by admin on Sat Dec 16 08:58:01 GMT 2023 , Edited by admin on Sat Dec 16 08:58:01 GMT 2023
PRIMARY
WIKIPEDIA
Copper(II) acetylacetonate
Created by admin on Sat Dec 16 08:58:01 GMT 2023 , Edited by admin on Sat Dec 16 08:58:01 GMT 2023
PRIMARY
HSDB
256
Created by admin on Sat Dec 16 08:58:01 GMT 2023 , Edited by admin on Sat Dec 16 08:58:01 GMT 2023
PRIMARY
ECHA (EC/EINECS)
236-477-9
Created by admin on Sat Dec 16 08:58:01 GMT 2023 , Edited by admin on Sat Dec 16 08:58:01 GMT 2023
PRIMARY
PUBCHEM
2723615
Created by admin on Sat Dec 16 08:58:01 GMT 2023 , Edited by admin on Sat Dec 16 08:58:01 GMT 2023
PRIMARY
FDA UNII
69QQY9TJ8M
Created by admin on Sat Dec 16 08:58:01 GMT 2023 , Edited by admin on Sat Dec 16 08:58:01 GMT 2023
PRIMARY